New small molecule inhibitors of MDM2 and the uses thereof

Details for Australian Patent Application No. 2007297823 (hide)

Owner The Regents of the University of Michigan

Inventors Wang, Shaomeng; Chen, Jianyong; Qin, Dongguang; Yu, Shanghai

Agent Spruson & Ferguson

Pub. Number AU-B-2007297823

PCT Pub. Number WO2008/036168

Priority 60/841,150 30.08.06 US

Filing date 30 August 2007

Wipo publication date 27 March 2008

Acceptance publication date 19 April 2012

International Classifications

C07D 209/96 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/497 (2006.01)

A61K 31/5377 (2006.01)

C07D 211/06 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

26 March 2009 PCT application entered the National Phase

  PCT publication WO2008/036168 Priority application(s): WO2008/036168

19 April 2012 Application Accepted

  Published as AU-B-2007297823

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297827-Preparation of substituted morphinan-6-ones and salts and intermediates thereof

2007297821-Method and apparatus for scrim embedment into wet processed panels